Search Results 1611-1620 of 19544 for Hemoglobin

  1. Mayo Clinic Biobank - Other Health Conditions

    D., is researching bilirubin metabolism. Bilirubin is the breakdown product of hemoglobin in the liver and acts as a diagnostic marker for different liver and ...

  2. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

    Hemoglobin ≥ 8 g/dL or ≥ 5 mmol/L;; Alanine aminotransferase (ALT), aspartate aminotransferase (AST) ≤ 3 x upper limit of normal (ULN) and total bilirubin ...

  4. A Study to Evaluate Ulixertinib to Treat Patients with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100 x 10^9 cells/L;; Absolute neutrophil count ≥ 1.5 x 10^9 cells/L). Adequate cardiac function: Left ventricular ...

  5. Vitamin E Supplements Not Recommended for Those with Diabetes - Mayo Clinic News Network

    May 7, 2010 Dear Mayo Clinic: I have heard that vitamin E can be harmful to diabetics with heart problems. Can you tell me more about this?

  6. Low White Blood Cell Count Not Always a Sign of Medical Problem - Mayo Clinic News Network

    February 4, 2011. Dear Mayo Clinic: I was told after my recent physical that my white blood cell count was low. Is this something to be concerned about?

  7. Pharmacokinetic and Safety Study of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects with Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dL. Subject has the following blood chemistry levels at screening (obtained ≤ 14 days prior to starting Cycle 1 Day 1):. AST (SGOT) ...

  8. A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer - Mayo Clinic

    ... hemoglobin ≥ 10 g/dL, GFR ≥ 50 mL/min, may not have NYHA Class III heart failure;; Eligible for pembrolizumab (Dose-escalation cohorts, Cohorts A, B, G and ...

  9. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN or direct bilirubin ...

  10. How preeclampsia accelerates aging in women - Mayo Clinic News Network

    Dr. Vesna Garovic has shown that women with preeclampsia undergo a state of accelerated aging that propels them down the path of developing age-related ...